Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > Lets have a real discussion!

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Oct 13, 2021 1:36pm

227 Views

Post# 34001872

RE:Lets have a real discussion!

An uplist on it's own will not do anything IMO. Need to get a deal done first to show some credibility. Then I'd uplist and then I'd release results on other patients in the trial. That would move the price and then I'd get a trial started with a pharma partner using the conformal coating tech without anti rejection meds and we'd be off to the races. The plan is simple, but we need someone who can execute said plan in a timely manner.

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions